Aaron P. Jansen

1.5k total citations
9 papers, 1.3k citations indexed

About

Aaron P. Jansen is a scholar working on Molecular Biology, Biochemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Aaron P. Jansen has authored 9 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Biochemistry and 1 paper in Cellular and Molecular Neuroscience. Recurrent topics in Aaron P. Jansen's work include Polyamine Metabolism and Applications (5 papers), Cancer-related gene regulation (3 papers) and RNA Research and Splicing (3 papers). Aaron P. Jansen is often cited by papers focused on Polyamine Metabolism and Applications (5 papers), Cancer-related gene regulation (3 papers) and RNA Research and Splicing (3 papers). Aaron P. Jansen collaborates with scholars based in United States, Germany and Canada. Aaron P. Jansen's co-authors include Nancy H. Colburn, Corinne E. Camalier, Hsin‐Sheng Yang, Sylvain V. Costes, Nahum Sonenberg, Xiaojing Zheng, Anton A. Komar, Stephen Lockett, William C. Merrick and Ajit Kumar Verma and has published in prestigious journals such as Molecular and Cellular Biology, Cancer and Cancer Research.

In The Last Decade

Aaron P. Jansen

9 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron P. Jansen United States 8 1.1k 413 236 131 85 9 1.3k
Valentina Appierto Italy 20 787 0.7× 450 1.1× 204 0.9× 84 0.6× 86 1.0× 36 1.1k
Magdalena Bachvarova Canada 22 718 0.7× 255 0.6× 245 1.0× 229 1.7× 78 0.9× 35 1.2k
Hugues Ripoche France 14 653 0.6× 307 0.7× 226 1.0× 93 0.7× 89 1.0× 20 992
Duc‐Hiep Bach South Korea 16 810 0.8× 494 1.2× 303 1.3× 111 0.8× 84 1.0× 21 1.2k
Marco Cirò Italy 10 859 0.8× 225 0.5× 320 1.4× 83 0.6× 87 1.0× 11 1.1k
Georgia Konstantinidou Switzerland 18 920 0.9× 450 1.1× 374 1.6× 90 0.7× 94 1.1× 26 1.3k
Yuqian Yan United States 19 1.0k 1.0× 278 0.7× 392 1.7× 98 0.7× 71 0.8× 37 1.4k
Geneviève Rodier France 16 1.1k 1.0× 325 0.8× 419 1.8× 121 0.9× 199 2.3× 26 1.3k
Qiaofen Fu China 15 803 0.8× 492 1.2× 334 1.4× 202 1.5× 58 0.7× 31 1.1k
Yeonjoo Jung South Korea 18 689 0.7× 182 0.4× 241 1.0× 67 0.5× 76 0.9× 26 953

Countries citing papers authored by Aaron P. Jansen

Since Specialization
Citations

This map shows the geographic impact of Aaron P. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron P. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron P. Jansen more than expected).

Fields of papers citing papers by Aaron P. Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron P. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron P. Jansen. The network helps show where Aaron P. Jansen may publish in the future.

Co-authorship network of co-authors of Aaron P. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron P. Jansen. A scholar is included among the top collaborators of Aaron P. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron P. Jansen. Aaron P. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Schmid, Tobias, Aaron P. Jansen, Alyson R. Baker, et al.. (2008). Translation Inhibitor Pdcd4 Is Targeted for Degradation during Tumor Promotion. Cancer Research. 68(5). 1254–1260. 126 indexed citations
3.
Colburn, Nancy H., Hsin‐Sheng Yang, & Aaron P. Jansen. (2006). Pdcd4 targets eIF4A to inhibit translation, transcription, tumorigenesis, and invasion. European Journal of Cancer Supplements. 4(6). 23–23. 3 indexed citations
4.
Jansen, Aaron P., Corinne E. Camalier, & Nancy H. Colburn. (2005). Epidermal Expression of the Translation Inhibitor Programmed Cell Death 4 Suppresses Tumorigenesis. Cancer Research. 65(14). 6034–6041. 190 indexed citations
5.
Jansen, Aaron P., et al.. (2004). Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Molecular Cancer Therapeutics. 3(2). 103–110. 115 indexed citations
6.
Yang, Hsin‐Sheng, Aaron P. Jansen, Anton A. Komar, et al.. (2002). The Transformation Suppressor Pdcd4 Is a Novel Eukaryotic Translation Initiation Factor 4A Binding Protein That Inhibits Translation. Molecular and Cellular Biology. 23(1). 26–37. 420 indexed citations
7.
Jansen, Aaron P., Nancy E. Dreckschmidt, Eric G. Verwiebe, et al.. (2001). Relation of the induction of epidermal ornithine decarboxylase and hyperplasia to the different skin tumor-promotion susceptibilities of protein kinase C?, -? and -? transgenic mice. International Journal of Cancer. 93(5). 635–643. 52 indexed citations
8.
Yang, Hsin‐Sheng, Aaron P. Jansen, Rajalakshmi Nair, et al.. (2001). A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation. Oncogene. 20(6). 669–676. 168 indexed citations
9.
Jansen, Aaron P., Nancy H. Colburn, & Ajit Kumar Verma. (1999). Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation. Oncogene. 18(42). 5806–5813. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026